English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1157]
News [2525]
Articles [155]
Editorials [8]
Conferences [103]
elearning [18]
Antibiotic found to kill tumour cells with DNA-repair glitch
Antibiotic found to kill tumour cells with DNA-repair glitch
PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions
PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions
Researchers identify protein responsible for prostate cancer's aggressiveness
Researchers identify protein responsible for prostate cancer's aggressiveness
ASCO 2021: No survival difference for frontline combination regimens in real world intermediate-risk and poor-risk clear cell RCC
ASCO 2021: No survival difference for frontline combination regimens in real world intermediate-risk and poor-risk...
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line...
ASCO 2021: Post-surgery immunotherapy extends disease-free survival for select patients with kidney cancer
ASCO 2021: Post-surgery immunotherapy extends disease-free survival for select patients with kidney cancer
ASCO 2021: Targeted radiotherapy offers new treatment option for patients previously treated for metastatic castration-resistant prostate cancer
ASCO 2021: Targeted radiotherapy offers new treatment option for patients previously treated for metastatic...
Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
When should screening start for men with a family history of prostate cancer?
When should screening start for men with a family history of prostate cancer?
Researchers identify new drug target for treating aggressive prostate cancer
Researchers identify new drug target for treating aggressive prostate cancer
<1...6465666768...253>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top